Caveat emptor NICE: biased use of cost-effectiveness is inefficient and inequitable [version 1; referees: 2 approved]
Concern with the threshold applied in cost-effectiveness analyses by bodies such as NICE distracts attention from their biased use of the principle. The bias results from the prior requirement that an intervention be effective (usually 'clinically effective') before its cost-effectiveness...
Main Authors: | Jack Dowie, Mette Kjer Kaltoft, Jesper Bo Nielsen, Glenn Salkeld |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2015-10-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/4-1078/v1 |
Similar Items
-
Caveat emptor
by: Johannes Platschek
Published: (2011-01-01) -
Caveat emptor
by: Yashant Aswani, et al.
Published: (2015-10-01) -
Increasing User Involvement in Health Care and Health Research Simultaneously: A Proto-Protocol for "Person-as-Researcher" and Online Decision Support Tools
by: Kaltoft, Mette Kjer, et al.
Published: (2014-11-01) -
Thucydides’ Trap : Caveat Emptor
by: Chan, Steve
Published: (2019) -
Caveat Emptor Doesn’t Cut It
by: Rachel Cooper
Published: (2013-10-01)